Shayu Deshpande
Researcher
Also affiliated: Memorial Sloan Kettering Cancer Center (2009–2013); Kettering University (2009); NeuroDevelopment Center (2012); Myeloma UK (2018); Institute of Developmental Physiology (2012); Winthrop Rockefeller Foundation (2020–2023)
Faculty Researcher
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Shayu Deshpande's research investigates the evolutionary pathways and molecular mechanisms underlying multiple myeloma, a hematologic malignancy. Their work has characterized the progression of multiple myeloma from smoldering states to relapse-refractory disease, utilizing single-cell analysis to examine the role of the immune microenvironment. Deshpande is also engaged in public health research focused on improving access to healthcare for children in rural areas. This includes the development and study of school-based enhanced hearing screening programs combined with specialty telehealth follow-up, with protocols for trials in rural Alaska and Kentucky. These initiatives aim to address health disparities by leveraging technology to connect underserved children with necessary medical care. Deshpande has published 46 papers, accumulating over 1,050 citations and an h-index of 15.
Metrics
- h-index: 15
- Publications: 46
- Citations: 1,065
Selected Publications
-
Transforming Access to Hearing Care: Community Perspectives on School-Based Telehealth in Rural Appalachia (2025)
-
Improving Access to Specialty Care for Rural Children Using Enhanced Hearing Screening and Specialty Telehealth Follow-Up in Rural Kentucky Schools: Protocol for a Hybrid Effectiveness-Implementation Stepped Wedge, Cluster-Randomized Controlled Trial (Appalachian STAR Trial) (2025)
-
School-based enhanced hearing screening and specialty telehealth follow-up for hearing loss among children in rural Alaska: study protocol for a hybrid effectiveness-implementation stepped wedge, cluster-randomized controlled trial (North STAR trial) (2025)
-
School-Based Enhanced Hearing Screening and Specialty Telehealth Follow-Up for Hearing Loss Among Children in Rural Alaska: Study Protocol for a Hybrid Effectiveness-Implementation Stepped Wedge, Cluster-Randomized Controlled Trial (North STAR Trial) (2025)
-
Characterizing the role of the immune microenvironment in multiple myeloma progression at a single-cell level (2022)
-
The spatio-temporal evolution of multiple myeloma from baseline to relapse-refractory states (2022)
-
Interaction of the Class A Scavenger Receptor with Multiple Myeloma Cells (2022)
-
The Spatio-Temporal Evolution of Multiple Myeloma from Baseline to Relapse-Refractory States (2022)
-
The molecular make up of smoldering myeloma highlights the evolutionary pathways leading to multiple myeloma (2021)
-
Additional file 2 of The functional epigenetic landscape of aberrant gene expression in molecular subgroups of newly diagnosed multiple myeloma (2020)
-
The functional epigenetic landscape of aberrant gene expression in molecular subgroups of newly diagnosed multiple myeloma (2020)
-
Monitoring treatment response and disease progression in myeloma with circulating cell‐free DNA (2020)
-
The functional epigenetic landscape of aberrant gene expression in molecular subgroups of newly diagnosed multiple myeloma (2020)
-
Genomic analysis of primary plasma cell leukemia reveals complex structural alterations and high-risk mutational patterns (2020)
-
Analysis of the Sub-Clonal Structure of Smoldering Myeloma over Time Provides a New Means of Disease Monitoring and Highlights Evolutionary Trajectories Leading to Myeloma (2019)
Collaboration Network
Top Collaborators
- The molecular make up of smoldering myeloma highlights the evolutionary pathways leading to multiple myeloma
- The spatio-temporal evolution of multiple myeloma from baseline to relapse-refractory states
- Characterizing the role of the immune microenvironment in multiple myeloma progression at a single-cell level
- The Spatio-Temporal Evolution of Multiple Myeloma from Baseline to Relapse-Refractory States
- The molecular make up of smoldering myeloma highlights the evolutionary pathways leading to multiple myeloma
- The spatio-temporal evolution of multiple myeloma from baseline to relapse-refractory states
- Characterizing the role of the immune microenvironment in multiple myeloma progression at a single-cell level
- The Spatio-Temporal Evolution of Multiple Myeloma from Baseline to Relapse-Refractory States
- The molecular make up of smoldering myeloma highlights the evolutionary pathways leading to multiple myeloma
- The spatio-temporal evolution of multiple myeloma from baseline to relapse-refractory states
- Characterizing the role of the immune microenvironment in multiple myeloma progression at a single-cell level
- The Spatio-Temporal Evolution of Multiple Myeloma from Baseline to Relapse-Refractory States
- The molecular make up of smoldering myeloma highlights the evolutionary pathways leading to multiple myeloma
- The spatio-temporal evolution of multiple myeloma from baseline to relapse-refractory states
- Characterizing the role of the immune microenvironment in multiple myeloma progression at a single-cell level
- The Spatio-Temporal Evolution of Multiple Myeloma from Baseline to Relapse-Refractory States
- The molecular make up of smoldering myeloma highlights the evolutionary pathways leading to multiple myeloma
- The spatio-temporal evolution of multiple myeloma from baseline to relapse-refractory states
- Characterizing the role of the immune microenvironment in multiple myeloma progression at a single-cell level
- The Spatio-Temporal Evolution of Multiple Myeloma from Baseline to Relapse-Refractory States
- The molecular make up of smoldering myeloma highlights the evolutionary pathways leading to multiple myeloma
- The spatio-temporal evolution of multiple myeloma from baseline to relapse-refractory states
- Characterizing the role of the immune microenvironment in multiple myeloma progression at a single-cell level
- The Spatio-Temporal Evolution of Multiple Myeloma from Baseline to Relapse-Refractory States
- The molecular make up of smoldering myeloma highlights the evolutionary pathways leading to multiple myeloma
- The spatio-temporal evolution of multiple myeloma from baseline to relapse-refractory states
- Characterizing the role of the immune microenvironment in multiple myeloma progression at a single-cell level
- The Spatio-Temporal Evolution of Multiple Myeloma from Baseline to Relapse-Refractory States
- The molecular make up of smoldering myeloma highlights the evolutionary pathways leading to multiple myeloma
- The spatio-temporal evolution of multiple myeloma from baseline to relapse-refractory states
- The Spatio-Temporal Evolution of Multiple Myeloma from Baseline to Relapse-Refractory States
- The molecular make up of smoldering myeloma highlights the evolutionary pathways leading to multiple myeloma
- The spatio-temporal evolution of multiple myeloma from baseline to relapse-refractory states
- The Spatio-Temporal Evolution of Multiple Myeloma from Baseline to Relapse-Refractory States
- The molecular make up of smoldering myeloma highlights the evolutionary pathways leading to multiple myeloma
- The spatio-temporal evolution of multiple myeloma from baseline to relapse-refractory states
- The Spatio-Temporal Evolution of Multiple Myeloma from Baseline to Relapse-Refractory States
- The molecular make up of smoldering myeloma highlights the evolutionary pathways leading to multiple myeloma
- The spatio-temporal evolution of multiple myeloma from baseline to relapse-refractory states
- The Spatio-Temporal Evolution of Multiple Myeloma from Baseline to Relapse-Refractory States
- The molecular make up of smoldering myeloma highlights the evolutionary pathways leading to multiple myeloma
- The spatio-temporal evolution of multiple myeloma from baseline to relapse-refractory states
- The Spatio-Temporal Evolution of Multiple Myeloma from Baseline to Relapse-Refractory States
- The spatio-temporal evolution of multiple myeloma from baseline to relapse-refractory states
- Characterizing the role of the immune microenvironment in multiple myeloma progression at a single-cell level
- The Spatio-Temporal Evolution of Multiple Myeloma from Baseline to Relapse-Refractory States
- The spatio-temporal evolution of multiple myeloma from baseline to relapse-refractory states
- Characterizing the role of the immune microenvironment in multiple myeloma progression at a single-cell level
- The Spatio-Temporal Evolution of Multiple Myeloma from Baseline to Relapse-Refractory States
- The spatio-temporal evolution of multiple myeloma from baseline to relapse-refractory states
- Characterizing the role of the immune microenvironment in multiple myeloma progression at a single-cell level
- The Spatio-Temporal Evolution of Multiple Myeloma from Baseline to Relapse-Refractory States
Similar Researchers
Based on overlapping research topics